Voices
Explore Innovative Approaches Targeting PRAME+ Cancers with Cedrik M. Britten – SITC
Cedrik M. Britten/LinkedIn

Explore Innovative Approaches Targeting PRAME+ Cancers with Cedrik M. Britten – SITC

Society for Immunotherapy of Cancer (SITC) shared a post on LinkedIn:

“Explore innovative approaches targeting PRAME+ cancers with Cedrik M. Britten, MD. Learn about the clinical development of TCR T-cell therapies and bispecific T-cell engagers.

Learn more and register.”

Cedrik M. Britten

Other articles about Immunotherapy on OncoDaily.

cancer Cedrik M. Britten immunotherapy OncoDaily Oncology SITC Society for Immunotherapy of Cancer (SITC)